カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のカルバペネム系抗生物質市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Carbapenem Antibiotics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19210）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19210
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：105
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のカルバペネム系抗生物質市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

カルバペネム系抗生物質市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のカルバペネム系抗生物質の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

カルバペネム系抗生物質市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・メロペネム、ドニペネム、イミペネム、チピペネム、その他

用途別セグメントは次のように区分されます。
・小売薬局、オンライン薬局、病院薬局

世界のカルバペネム系抗生物質市場の主要な市場プレーヤーは以下のとおりです。
・ACS Dobfar S.p.A、Iterum Therapeutics plc、DAEWOONG PHARMACEUTICAL CO.,LTD、Aurobindo Pharma Ltd、Gland Pharma Limited、Merck & Co., Inc.、Sumitomo Dainippon Pharma Co., Ltd.、Savior Lifetec、Pfizer Inc.、Spero Therapeutics

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、カルバペネム系抗生物質製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なカルバペネム系抗生物質メーカーの企業概要、2019年～2022年までのカルバペネム系抗生物質の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なカルバペネム系抗生物質メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別カルバペネム系抗生物質の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのカルバペネム系抗生物質の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのカルバペネム系抗生物質市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびカルバペネム系抗生物質の産業チェーンを掲載しています。
・第13、14、15章では、カルバペネム系抗生物質の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- カルバペネム系抗生物質の概要
- 種類別分析（2017年vs2021年vs2028年）：メロペネム、ドニペネム、イミペネム、チピペネム、その他
- 用途別分析（2017年vs2021年vs2028年）：小売薬局、オンライン薬局、病院薬局
- 世界のカルバペネム系抗生物質市場規模・予測
- 世界のカルバペネム系抗生物質生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- ACS Dobfar S.p.A、Iterum Therapeutics plc、DAEWOONG PHARMACEUTICAL CO.,LTD、Aurobindo Pharma Ltd、Gland Pharma Limited、Merck & Co., Inc.、Sumitomo Dainippon Pharma Co., Ltd.、Savior Lifetec、Pfizer Inc.、Spero Therapeutics
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：メロペネム、ドニペネム、イミペネム、チピペネム、その他
・用途別分析2017年-2028年：小売薬局、オンライン薬局、病院薬局
・カルバペネム系抗生物質の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・カルバペネム系抗生物質のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・カルバペネム系抗生物質のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・カルバペネム系抗生物質の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・カルバペネム系抗生物質の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Carbapenem Antibiotics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Carbapenem Antibiotics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Retail Pharmacy accounting for % of the Carbapenem Antibiotics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Meropenem segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Carbapenem Antibiotics include ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, and Gland Pharma Limited, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Carbapenem Antibiotics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Meropenem
Donipenem
Imipenem
Tipipenem
Others
Market segment by Application can be divided into
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
The key market players for global Carbapenem Antibiotics market are listed below:
ACS Dobfar S.p.A
Iterum Therapeutics plc
DAEWOONG PHARMACEUTICAL CO.,LTD
Aurobindo Pharma Ltd
Gland Pharma Limited
Merck & Co., Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Savior Lifetec
Pfizer Inc.
Spero Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Carbapenem Antibiotics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Carbapenem Antibiotics, with price, sales, revenue and global market share of Carbapenem Antibiotics from 2019 to 2022.
Chapter 3, the Carbapenem Antibiotics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Carbapenem Antibiotics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Carbapenem Antibiotics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Carbapenem Antibiotics.
Chapter 13, 14, and 15, to describe Carbapenem Antibiotics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Carbapenem Antibiotics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Carbapenem Antibiotics Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Meropenem
1.2.3 Donipenem
1.2.4 Imipenem
1.2.5 Tipipenem
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Carbapenem Antibiotics Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Retail Pharmacy
1.3.3 Online Pharmacy
1.3.4 Hospital Pharmacy
1.4 Global Carbapenem Antibiotics Market Size & Forecast
1.4.1 Global Carbapenem Antibiotics Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Carbapenem Antibiotics Sales in Volume (2017-2028)
1.4.3 Global Carbapenem Antibiotics Price (2017-2028)
1.5 Global Carbapenem Antibiotics Production Capacity Analysis
1.5.1 Global Carbapenem Antibiotics Total Production Capacity (2017-2028)
1.5.2 Global Carbapenem Antibiotics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Carbapenem Antibiotics Market Drivers
1.6.2 Carbapenem Antibiotics Market Restraints
1.6.3 Carbapenem Antibiotics Trends Analysis
2 Manufacturers Profiles
2.1 ACS Dobfar S.p.A
2.1.1 ACS Dobfar S.p.A Details
2.1.2 ACS Dobfar S.p.A Major Business
2.1.3 ACS Dobfar S.p.A Carbapenem Antibiotics Product and Services
2.1.4 ACS Dobfar S.p.A Carbapenem Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Iterum Therapeutics plc
2.2.1 Iterum Therapeutics plc Details
2.2.2 Iterum Therapeutics plc Major Business
2.2.3 Iterum Therapeutics plc Carbapenem Antibiotics Product and Services
2.2.4 Iterum Therapeutics plc Carbapenem Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 DAEWOONG PHARMACEUTICAL CO.,LTD
2.3.1 DAEWOONG PHARMACEUTICAL CO.,LTD Details
2.3.2 DAEWOONG PHARMACEUTICAL CO.,LTD Major Business
2.3.3 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Product and Services
2.3.4 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Aurobindo Pharma Ltd
2.4.1 Aurobindo Pharma Ltd Details
2.4.2 Aurobindo Pharma Ltd Major Business
2.4.3 Aurobindo Pharma Ltd Carbapenem Antibiotics Product and Services
2.4.4 Aurobindo Pharma Ltd Carbapenem Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Gland Pharma Limited
2.5.1 Gland Pharma Limited Details
2.5.2 Gland Pharma Limited Major Business
2.5.3 Gland Pharma Limited Carbapenem Antibiotics Product and Services
2.5.4 Gland Pharma Limited Carbapenem Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Merck & Co., Inc.
2.6.1 Merck & Co., Inc. Details
2.6.2 Merck & Co., Inc. Major Business
2.6.3 Merck & Co., Inc. Carbapenem Antibiotics Product and Services
2.6.4 Merck & Co., Inc. Carbapenem Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sumitomo Dainippon Pharma Co., Ltd.
2.7.1 Sumitomo Dainippon Pharma Co., Ltd. Details
2.7.2 Sumitomo Dainippon Pharma Co., Ltd. Major Business
2.7.3 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Product and Services
2.7.4 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Savior Lifetec
2.8.1 Savior Lifetec Details
2.8.2 Savior Lifetec Major Business
2.8.3 Savior Lifetec Carbapenem Antibiotics Product and Services
2.8.4 Savior Lifetec Carbapenem Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pfizer Inc.
2.9.1 Pfizer Inc. Details
2.9.2 Pfizer Inc. Major Business
2.9.3 Pfizer Inc. Carbapenem Antibiotics Product and Services
2.9.4 Pfizer Inc. Carbapenem Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Spero Therapeutics
2.10.1 Spero Therapeutics Details
2.10.2 Spero Therapeutics Major Business
2.10.3 Spero Therapeutics Carbapenem Antibiotics Product and Services
2.10.4 Spero Therapeutics Carbapenem Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Carbapenem Antibiotics Breakdown Data by Manufacturer
3.1 Global Carbapenem Antibiotics Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Carbapenem Antibiotics Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Carbapenem Antibiotics
3.4 Market Concentration Rate
3.4.1 Top 3 Carbapenem Antibiotics Manufacturer Market Share in 2021
3.4.2 Top 6 Carbapenem Antibiotics Manufacturer Market Share in 2021
3.5 Global Carbapenem Antibiotics Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Carbapenem Antibiotics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Carbapenem Antibiotics Market Size by Region
4.1.1 Global Carbapenem Antibiotics Sales in Volume by Region (2017-2028)
4.1.2 Global Carbapenem Antibiotics Revenue by Region (2017-2028)
4.2 North America Carbapenem Antibiotics Revenue (2017-2028)
4.3 Europe Carbapenem Antibiotics Revenue (2017-2028)
4.4 Asia-Pacific Carbapenem Antibiotics Revenue (2017-2028)
4.5 South America Carbapenem Antibiotics Revenue (2017-2028)
4.6 Middle East and Africa Carbapenem Antibiotics Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Carbapenem Antibiotics Sales in Volume by Type (2017-2028)
5.2 Global Carbapenem Antibiotics Revenue by Type (2017-2028)
5.3 Global Carbapenem Antibiotics Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Carbapenem Antibiotics Sales in Volume by Application (2017-2028)
6.2 Global Carbapenem Antibiotics Revenue by Application (2017-2028)
6.3 Global Carbapenem Antibiotics Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Carbapenem Antibiotics Sales by Type (2017-2028)
7.2 North America Carbapenem Antibiotics Sales by Application (2017-2028)
7.3 North America Carbapenem Antibiotics Market Size by Country
7.3.1 North America Carbapenem Antibiotics Sales in Volume by Country (2017-2028)
7.3.2 North America Carbapenem Antibiotics Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Carbapenem Antibiotics Sales by Type (2017-2028)
8.2 Europe Carbapenem Antibiotics Sales by Application (2017-2028)
8.3 Europe Carbapenem Antibiotics Market Size by Country
8.3.1 Europe Carbapenem Antibiotics Sales in Volume by Country (2017-2028)
8.3.2 Europe Carbapenem Antibiotics Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Carbapenem Antibiotics Sales by Type (2017-2028)
9.2 Asia-Pacific Carbapenem Antibiotics Sales by Application (2017-2028)
9.3 Asia-Pacific Carbapenem Antibiotics Market Size by Region
9.3.1 Asia-Pacific Carbapenem Antibiotics Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Carbapenem Antibiotics Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Carbapenem Antibiotics Sales by Type (2017-2028)
10.2 South America Carbapenem Antibiotics Sales by Application (2017-2028)
10.3 South America Carbapenem Antibiotics Market Size by Country
10.3.1 South America Carbapenem Antibiotics Sales in Volume by Country (2017-2028)
10.3.2 South America Carbapenem Antibiotics Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Carbapenem Antibiotics Sales by Type (2017-2028)
11.2 Middle East & Africa Carbapenem Antibiotics Sales by Application (2017-2028)
11.3 Middle East & Africa Carbapenem Antibiotics Market Size by Country
11.3.1 Middle East & Africa Carbapenem Antibiotics Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Carbapenem Antibiotics Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Carbapenem Antibiotics and Key Manufacturers
12.2 Manufacturing Costs Percentage of Carbapenem Antibiotics
12.3 Carbapenem Antibiotics Production Process
12.4 Carbapenem Antibiotics Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Carbapenem Antibiotics Typical Distributors
13.3 Carbapenem Antibiotics Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Carbapenem Antibiotics Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Carbapenem Antibiotics Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ACS Dobfar S.p.A Basic Information, Manufacturing Base and Competitors
Table 4. ACS Dobfar S.p.A Major Business
Table 5. ACS Dobfar S.p.A Carbapenem Antibiotics Product and Services
Table 6. ACS Dobfar S.p.A Carbapenem Antibiotics Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Iterum Therapeutics plc Basic Information, Manufacturing Base and Competitors
Table 8. Iterum Therapeutics plc Major Business
Table 9. Iterum Therapeutics plc Carbapenem Antibiotics Product and Services
Table 10. Iterum Therapeutics plc Carbapenem Antibiotics Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. DAEWOONG PHARMACEUTICAL CO.,LTD Basic Information, Manufacturing Base and Competitors
Table 12. DAEWOONG PHARMACEUTICAL CO.,LTD Major Business
Table 13. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Product and Services
Table 14. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem Antibiotics Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 16. Aurobindo Pharma Ltd Major Business
Table 17. Aurobindo Pharma Ltd Carbapenem Antibiotics Product and Services
Table 18. Aurobindo Pharma Ltd Carbapenem Antibiotics Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Gland Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 20. Gland Pharma Limited Major Business
Table 21. Gland Pharma Limited Carbapenem Antibiotics Product and Services
Table 22. Gland Pharma Limited Carbapenem Antibiotics Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Merck & Co., Inc. Major Business
Table 25. Merck & Co., Inc. Carbapenem Antibiotics Product and Services
Table 26. Merck & Co., Inc. Carbapenem Antibiotics Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sumitomo Dainippon Pharma Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Sumitomo Dainippon Pharma Co., Ltd. Major Business
Table 29. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Product and Services
Table 30. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem Antibiotics Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Savior Lifetec Basic Information, Manufacturing Base and Competitors
Table 32. Savior Lifetec Major Business
Table 33. Savior Lifetec Carbapenem Antibiotics Product and Services
Table 34. Savior Lifetec Carbapenem Antibiotics Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Inc. Major Business
Table 37. Pfizer Inc. Carbapenem Antibiotics Product and Services
Table 38. Pfizer Inc. Carbapenem Antibiotics Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Spero Therapeutics Basic Information, Manufacturing Base and Competitors
Table 40. Spero Therapeutics Major Business
Table 41. Spero Therapeutics Carbapenem Antibiotics Product and Services
Table 42. Spero Therapeutics Carbapenem Antibiotics Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Carbapenem Antibiotics Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
Table 44. Global Carbapenem Antibiotics Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Carbapenem Antibiotics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Carbapenem Antibiotics Production Capacity by Company, (Tons): 2020 VS 2021
Table 47. Head Office and Carbapenem Antibiotics Production Site of Key Manufacturer
Table 48. Carbapenem Antibiotics New Entrant and Capacity Expansion Plans
Table 49. Carbapenem Antibiotics Mergers & Acquisitions in the Past Five Years
Table 50. Global Carbapenem Antibiotics Sales by Region (2017-2022) & (Tons)
Table 51. Global Carbapenem Antibiotics Sales by Region (2023-2028) & (Tons)
Table 52. Global Carbapenem Antibiotics Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Carbapenem Antibiotics Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Carbapenem Antibiotics Sales by Type (2017-2022) & (Tons)
Table 55. Global Carbapenem Antibiotics Sales by Type (2023-2028) & (Tons)
Table 56. Global Carbapenem Antibiotics Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Carbapenem Antibiotics Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Carbapenem Antibiotics Price by Type (2017-2022) & (US$/Kg)
Table 59. Global Carbapenem Antibiotics Price by Type (2023-2028) & (US$/Kg)
Table 60. Global Carbapenem Antibiotics Sales by Application (2017-2022) & (Tons)
Table 61. Global Carbapenem Antibiotics Sales by Application (2023-2028) & (Tons)
Table 62. Global Carbapenem Antibiotics Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Carbapenem Antibiotics Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Carbapenem Antibiotics Price by Application (2017-2022) & (US$/Kg)
Table 65. Global Carbapenem Antibiotics Price by Application (2023-2028) & (US$/Kg)
Table 66. North America Carbapenem Antibiotics Sales by Country (2017-2022) & (Tons)
Table 67. North America Carbapenem Antibiotics Sales by Country (2023-2028) & (Tons)
Table 68. North America Carbapenem Antibiotics Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Carbapenem Antibiotics Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Carbapenem Antibiotics Sales by Type (2017-2022) & (Tons)
Table 71. North America Carbapenem Antibiotics Sales by Type (2023-2028) & (Tons)
Table 72. North America Carbapenem Antibiotics Sales by Application (2017-2022) & (Tons)
Table 73. North America Carbapenem Antibiotics Sales by Application (2023-2028) & (Tons)
Table 74. Europe Carbapenem Antibiotics Sales by Country (2017-2022) & (Tons)
Table 75. Europe Carbapenem Antibiotics Sales by Country (2023-2028) & (Tons)
Table 76. Europe Carbapenem Antibiotics Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Carbapenem Antibiotics Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Carbapenem Antibiotics Sales by Type (2017-2022) & (Tons)
Table 79. Europe Carbapenem Antibiotics Sales by Type (2023-2028) & (Tons)
Table 80. Europe Carbapenem Antibiotics Sales by Application (2017-2022) & (Tons)
Table 81. Europe Carbapenem Antibiotics Sales by Application (2023-2028) & (Tons)
Table 82. Asia-Pacific Carbapenem Antibiotics Sales by Region (2017-2022) & (Tons)
Table 83. Asia-Pacific Carbapenem Antibiotics Sales by Region (2023-2028) & (Tons)
Table 84. Asia-Pacific Carbapenem Antibiotics Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Carbapenem Antibiotics Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Carbapenem Antibiotics Sales by Type (2017-2022) & (Tons)
Table 87. Asia-Pacific Carbapenem Antibiotics Sales by Type (2023-2028) & (Tons)
Table 88. Asia-Pacific Carbapenem Antibiotics Sales by Application (2017-2022) & (Tons)
Table 89. Asia-Pacific Carbapenem Antibiotics Sales by Application (2023-2028) & (Tons)
Table 90. South America Carbapenem Antibiotics Sales by Country (2017-2022) & (Tons)
Table 91. South America Carbapenem Antibiotics Sales by Country (2023-2028) & (Tons)
Table 92. South America Carbapenem Antibiotics Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Carbapenem Antibiotics Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Carbapenem Antibiotics Sales by Type (2017-2022) & (Tons)
Table 95. South America Carbapenem Antibiotics Sales by Type (2023-2028) & (Tons)
Table 96. South America Carbapenem Antibiotics Sales by Application (2017-2022) & (Tons)
Table 97. South America Carbapenem Antibiotics Sales by Application (2023-2028) & (Tons)
Table 98. Middle East & Africa Carbapenem Antibiotics Sales by Region (2017-2022) & (Tons)
Table 99. Middle East & Africa Carbapenem Antibiotics Sales by Region (2023-2028) & (Tons)
Table 100. Middle East & Africa Carbapenem Antibiotics Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Carbapenem Antibiotics Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Carbapenem Antibiotics Sales by Type (2017-2022) & (Tons)
Table 103. Middle East & Africa Carbapenem Antibiotics Sales by Type (2023-2028) & (Tons)
Table 104. Middle East & Africa Carbapenem Antibiotics Sales by Application (2017-2022) & (Tons)
Table 105. Middle East & Africa Carbapenem Antibiotics Sales by Application (2023-2028) & (Tons)
Table 106. Carbapenem Antibiotics Raw Material
Table 107. Key Manufacturers of Carbapenem Antibiotics Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Carbapenem Antibiotics Typical Distributors
Table 111. Carbapenem Antibiotics Typical Customers
List of Figures
Figure 1. Carbapenem Antibiotics Picture
Figure 2. Global Carbapenem Antibiotics Revenue Market Share by Type in 2021
Figure 3. Meropenem
Figure 4. Donipenem
Figure 5. Imipenem
Figure 6. Tipipenem
Figure 7. Others
Figure 8. Global Carbapenem Antibiotics Revenue Market Share by Application in 2021
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Hospital Pharmacy
Figure 12. Global Carbapenem Antibiotics Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
Figure 13. Global Carbapenem Antibiotics Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Carbapenem Antibiotics Sales (2017-2028) & (Tons)
Figure 15. Global Carbapenem Antibiotics Price (2017-2028) & (US$/Kg)
Figure 16. Global Carbapenem Antibiotics Production Capacity (2017-2028) & (Tons)
Figure 17. Global Carbapenem Antibiotics Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Carbapenem Antibiotics Market Drivers
Figure 19. Carbapenem Antibiotics Market Restraints
Figure 20. Carbapenem Antibiotics Market Trends
Figure 21. Global Carbapenem Antibiotics Sales Market Share by Manufacturer in 2021
Figure 22. Global Carbapenem Antibiotics Revenue Market Share by Manufacturer in 2021
Figure 23. Carbapenem Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Carbapenem Antibiotics Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Carbapenem Antibiotics Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Carbapenem Antibiotics Sales Market Share by Region (2017-2028)
Figure 27. Global Carbapenem Antibiotics Revenue Market Share by Region (2017-2028)
Figure 28. North America Carbapenem Antibiotics Revenue (2017-2028) & (USD Million)
Figure 29. Europe Carbapenem Antibiotics Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Carbapenem Antibiotics Revenue (2017-2028) & (USD Million)
Figure 31. South America Carbapenem Antibiotics Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Carbapenem Antibiotics Revenue (2017-2028) & (USD Million)
Figure 33. Global Carbapenem Antibiotics Sales Market Share by Type (2017-2028)
Figure 34. Global Carbapenem Antibiotics Revenue Market Share by Type (2017-2028)
Figure 35. Global Carbapenem Antibiotics Price by Type (2017-2028) & (US$/Kg)
Figure 36. Global Carbapenem Antibiotics Sales Market Share by Application (2017-2028)
Figure 37. Global Carbapenem Antibiotics Revenue Market Share by Application (2017-2028)
Figure 38. Global Carbapenem Antibiotics Price by Application (2017-2028) & (US$/Kg)
Figure 39. North America Carbapenem Antibiotics Sales Market Share by Type (2017-2028)
Figure 40. North America Carbapenem Antibiotics Sales Market Share by Application (2017-2028)
Figure 41. North America Carbapenem Antibiotics Sales Market Share by Country (2017-2028)
Figure 42. North America Carbapenem Antibiotics Revenue Market Share by Country (2017-2028)
Figure 43. United States Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Carbapenem Antibiotics Sales Market Share by Type (2017-2028)
Figure 47. Europe Carbapenem Antibiotics Sales Market Share by Application (2017-2028)
Figure 48. Europe Carbapenem Antibiotics Sales Market Share by Country (2017-2028)
Figure 49. Europe Carbapenem Antibiotics Revenue Market Share by Country (2017-2028)
Figure 50. Germany Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Carbapenem Antibiotics Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Carbapenem Antibiotics Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Carbapenem Antibiotics Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Carbapenem Antibiotics Revenue Market Share by Region (2017-2028)
Figure 59. China Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Carbapenem Antibiotics Sales Market Share by Type (2017-2028)
Figure 66. South America Carbapenem Antibiotics Sales Market Share by Application (2017-2028)
Figure 67. South America Carbapenem Antibiotics Sales Market Share by Country (2017-2028)
Figure 68. South America Carbapenem Antibiotics Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Carbapenem Antibiotics Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Carbapenem Antibiotics Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Carbapenem Antibiotics Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Carbapenem Antibiotics Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Carbapenem Antibiotics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Carbapenem Antibiotics in 2021
Figure 80. Manufacturing Process Analysis of Carbapenem Antibiotics
Figure 81. Carbapenem Antibiotics Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のカルバペネムAPI市場2022年：市場規模予測（～2028年）
  • 世界の抗生物質医薬品有効成分(API)市場2022年：市場規模予測（～2028年）
  • 世界のテトラサイクリン系抗生物質市場2022年：市場規模予測（～2028年）
  • テトラサイクリン系抗生物質の世界市場2023年：クロルテトラサイクリン、オキシテトラサイクリン、テトラサイクリン、メチルオキシテトラサイクリン、ドキシサイクリン、ミノサイクリン
  • 世界の経口用抗生物質市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19210 )"世界のカルバペネム系抗生物質市場2022年：市場規模予測（～2028年）" (英文：Global Carbapenem Antibiotics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。